Demetra wants to move beyond implants. Can Masmec Biomed help build its surgical technology ecosystem?
Demetra and Masmec Biomed target AI, surgical navigation and robotics, but product scope, regulatory plans and timelines remain undisclosed.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
What Bruker’s DISQVER acquisition means for sepsis and bloodstream infection testing
Bruker acquires DISQVER from Noscendo, adding blood-based clinical metagenomics as it pursues diagnostic registration and wider adoption.
Medical Devices & Diagnostics
LRE Medical calls its IVD framework AI-ready, but the bigger opportunity starts before the algorithm
LRE Medical will showcase a connected IVD framework at ADLM 2026, highlighting cybersecurity, cloud services and future AI integration.
Medical Devices & Diagnostics
Rapid Medical’s steerable guidewire has FDA clearance, but can it shorten stroke access time?
Rapid Medical's DRIVEWIRE 35 gains FDA clearance for steerable vascular access, with stroke adoption now hinging on real-world workflow evidence.
Medical Devices & Diagnostics
i-Lumen Scientific begins U.S. pivotal trial of microcurrent therapy for dry AMD
i-Lumen Scientific, Inc. has randomized the first United States patient in its pivotal i-SIGHT2 study, beginning the domestic phase of a multinational trial evaluating whether low-level electrical stimulation delivered through a closed eyelid can improve visual function in people with intermediate-to-advanced dry age-related macular degeneration. The first U.S. randomization occurred at Texas Retina Associates in
Medical Devices & Diagnostics
Bluejay Diagnostics advances Symphony IL-6 test as SYMON-II enrollment concludes
Bluejay Diagnostics, Inc. has completed enrollment in its 750-patient SYMON-II clinical validation study, moving the investigational Symphony IL-6 test into the data-cleaning, sample-testing and statistical-analysis phase that will determine whether the company has a credible basis for a U.S. regulatory submission. The Nasdaq-listed diagnostics developer said enrollment finished earlier than originally anticipated across participating healthcare
Medical Devices & Diagnostics
Why is AdaptHealth selling a $592m diabetes business while Cardinal Health doubles down?
AdaptHealth will sell its Diabetes Health business to Cardinal Health for $235 million, shifting 225,000 patients into a larger home-care platform.
Medical Devices & Diagnostics
Poriferous patented a cranial implant designed to grow in on one side and let go on the other
Poriferous has patented DuraBloc, a dual-surface cranial implant designed to support tissue ingrowth while easing potential revision surgery.
Medical Devices & Diagnostics
No battery, no pill, no sensor: Why ANF Care’s unusual wearable is entering the United States
ANF Care is taking BioCoherence wearable discs to the United States, where evidence, claims and launch execution will shape adoption.
Medical Devices & Diagnostics
Why MultiDimension Technology’s tiny 50 nA chip could matter before a CGM is ever worn
MultiDimension Technology’s TMR1370 targets two-year CGM standby with 50 nA current, but device-level validation will decide its impact.